DLC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.582600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.862400E-01
Normal-vs-Stage2
5.443800E-01
Normal-vs-Stage3
4.429200E-01
Normal-vs-Stage4
9.834800E-01
Stage1-vs-Stage2
9.744400E-01
Stage1-vs-Stage3
9.304000E-01
Stage1-vs-Stage4
5.904400E-01
Stage2-vs-Stage3
9.587600E-01
Stage2-vs-Stage4
5.059200E-01
Stage3-vs-Stage4
5.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.536200E-01
Normal-vs-AfricanAmerican
6.392000E-01
Normal-vs-Asian
2.156200E-01
Caucasian-vs-AfricanAmerican
9.176200E-01
Caucasian-vs-Asian
3.081400E-01
AfricanAmerican-vs-Asian
3.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.492600E-01
Normal-vs-Female
7.068400E-01
Male-vs-Female
2.163000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.533000E-01
Normal-vs-Age(41-60Yrs)
8.627800E-01
Normal-vs-Age(61-80Yrs)
4.535000E-01
Normal-vs-Age(81-100Yrs)
9.514200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.092400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.057600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.286100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.394200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.115800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.281800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.775820E-01
Normal-vs-Daily Drinker
1.900020E-01
Normal-vs-Weekly Drinker
6.097600E-01
Normal-vs-Occasional Drinker
2.484200E-01
Normal-vs-Social Drinker
9.211200E-01
Non Drinker-vs-Daily Drinker
9.202200E-01
Non Drinker-vs-Weekly Drinker
1.226010E-01
Non Drinker-vs-Occasional Drinker
7.312800E-01
Non Drinker-vs-Social Drinker
1.260820E-01
Daily Drinker-vs-Weekly Drinker
1.315380E-01
Daily Drinker-vs-Occasional Drinker
6.850400E-01
Daily Drinker-vs-Social Drinker
1.206800E-01
Weekly Drinker-vs-Occasional Drinker
2.537000E-01
Weekly Drinker-vs-Social Drinker
4.676600E-01
Occasional Drinker-vs-Social Drinker
1.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.886200E-01
Normal-vs-Grade 2
6.269000E-01
Normal-vs-Grade 3
7.777800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.120200E-01
Grade 1-vs-Grade 3
4.968200E-01
Grade 1-vs-Grade 4
6.886200E-01
Grade 2-vs-Grade 3
3.051400E-01
Grade 2-vs-Grade 4
6.269000E-01
Grade 3-vs-Grade 4
7.777800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.285000E-01
Normal-vs-NonDiabetic
3.544000E-01
Diabetic-vs-NonDiabetic
1.590360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.950810E-01
Normal-vs-NoPancreatitis
5.751000E-01
Pancreatitis-vs-NoPancreatitis
3.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.504400E-01
Normal-vs-N1
5.639800E-01
N0-vs-N1
7.321400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.747700E-02
Normal-vs-TP53-NonMutant
3.122800E-01
TP53-Mutant-vs-TP53-NonMutant
1.151820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
